• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据胃食管反流情况,分析疑似非结核分枝杆菌肺病患者的下呼吸道微生物群。

Lower respiratory tract microbiota in patients with clinically suspected nontuberculous mycobacterial pulmonary disease according to the presence of gastroesophageal reflux.

机构信息

Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Department of Biomedical Sciences, Graduate School of Chonnam National University, Gwangju, Republic of Korea.

出版信息

PLoS One. 2024 Aug 28;19(8):e0309446. doi: 10.1371/journal.pone.0309446. eCollection 2024.

DOI:10.1371/journal.pone.0309446
PMID:39196906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11355550/
Abstract

Although gastroesophageal reflux has been recognized as one of the risk factors of nontuberculous mycobacterial pulmonary disease (NTM-PD) progression, the effect of reflux on the lower respiratory tract microbiota has not been studied in detail. We investigated the composition of the lower respiratory tract microbiota in patients with clinically suspected NTM-PD, comparing them based on the presence of reflux. Forty-seven patients suspected of having NTM-PD were enrolled and assigned according to presence of reflux (n = 22) and non- reflux (n = 25). We performed a pepsin ELISA assay to identify the presence of reflux and 16S ribosomal RNA gene amplicon sequencing to evaluate the microbiota in bronchoalveolar lavage fluid. There were no significant differences in the diversity or composition of the lower respiratory microbiota between the NTM-PD and non-NTM-PD groups. Bacterial richness was observed in the non-reflux group than in the reflux group [P = 0.03] and a cluster in the reflux group was observed. The reflux group showed a predominance for Pseudomonas aeruginosa or Staphylococcus aureus among the NTM-PD group and for P. aeruginosa, Haemophilus influenzae, Klebsiella pneumoniae, or Eikenella species among the non-NTM-PD group. The non-reflux groups presented diverse patterns. A linear discriminant analysis and volcano plot demonstrated that P. aeruginosa, H. haemolyticus, Selenomonas artemidis, and Dolosigranulum pigrum were specifically associated with the NTM-PD reflux group, while P. aeruginosa was specifically associated with the non-NTM-PD reflux group. These observations confirm that the lower respiratory microbiota is consistently altered by reflux but not in NTM-PD.

摘要

虽然胃食管反流已被认为是非结核分枝杆菌肺病(NTM-PD)进展的危险因素之一,但反流对下呼吸道微生物群的影响尚未详细研究。我们调查了临床疑似 NTM-PD 患者的下呼吸道微生物群组成,根据反流的存在对其进行了比较。共纳入 47 例疑似 NTM-PD 患者,并根据反流(n = 22)和非反流(n = 25)进行分组。我们通过胃蛋白酶 ELISA 检测来确定反流的存在,并通过 16S 核糖体 RNA 基因扩增子测序来评估支气管肺泡灌洗液中的微生物群。NTM-PD 和非 NTM-PD 组之间下呼吸道微生物群的多样性或组成均无显著差异。非反流组的细菌丰富度高于反流组[P = 0.03],且在反流组观察到一个聚类。反流组中 NTM-PD 组以铜绿假单胞菌或金黄色葡萄球菌为主,而非 NTM-PD 组中以铜绿假单胞菌、流感嗜血杆菌、肺炎克雷伯菌或爱肯菌属为主。非反流组呈现出多样化的模式。线性判别分析和火山图表明,铜绿假单胞菌、溶血嗜血杆菌、马氏球菌和猪巨吻棘头虫与 NTM-PD 反流组特异性相关,而铜绿假单胞菌与非 NTM-PD 反流组特异性相关。这些观察结果证实,下呼吸道微生物群确实受到反流的影响,但与 NTM-PD 无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/b7d10ecb6b7a/pone.0309446.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/23bde4fb3aec/pone.0309446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/7a33be42a103/pone.0309446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/93ff9393cbf5/pone.0309446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/133f5618ea93/pone.0309446.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/b7d10ecb6b7a/pone.0309446.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/23bde4fb3aec/pone.0309446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/7a33be42a103/pone.0309446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/93ff9393cbf5/pone.0309446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/133f5618ea93/pone.0309446.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e5/11355550/b7d10ecb6b7a/pone.0309446.g005.jpg

相似文献

1
Lower respiratory tract microbiota in patients with clinically suspected nontuberculous mycobacterial pulmonary disease according to the presence of gastroesophageal reflux.根据胃食管反流情况,分析疑似非结核分枝杆菌肺病患者的下呼吸道微生物群。
PLoS One. 2024 Aug 28;19(8):e0309446. doi: 10.1371/journal.pone.0309446. eCollection 2024.
2
Evaluation of the airway microbiome in nontuberculous mycobacteria disease.非结核分枝杆菌病气道微生物组评估。
Eur Respir J. 2018 Oct 25;52(4). doi: 10.1183/13993003.00810-2018. Print 2018 Oct.
3
Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的微生物学诊断。
Clin Chest Med. 2015 Mar;36(1):43-54. doi: 10.1016/j.ccm.2014.11.005. Epub 2014 Dec 18.
4
Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者的肺部和肠道微生物群多样性减少。
Korean J Intern Med. 2023 Nov;38(6):879-892. doi: 10.3904/kjim.2023.097. Epub 2023 Oct 23.
5
Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment.稳定非结核分枝杆菌肺病患者与需要治疗患者的痰微生物组比较。
BMC Microbiol. 2024 May 18;24(1):172. doi: 10.1186/s12866-024-03308-2.
6
Characterization of bronchoalveolar lavage fluid microbiota in acute exacerbations of bronchiectasis with non-tuberculous mycobacterial detection.支气管扩张症急性加重期非结核分枝杆菌检测时支气管肺泡灌洗液微生物群落特征。
Int J Infect Dis. 2024 Sep;146:107120. doi: 10.1016/j.ijid.2024.107120. Epub 2024 May 29.
7
The lung microbiota in Korean patients with non-tuberculous mycobacterial pulmonary disease.韩国非结核分枝杆菌肺病患者的肺部微生物组。
BMC Microbiol. 2021 Mar 18;21(1):84. doi: 10.1186/s12866-021-02141-1.
8
Coinfection With Multiple Nontuberculous Mycobacteria as a Possible Exacerbating Factor in Pulmonary Nontuberculous Mycobacteriosis: Clone Library Analysis Using the 16S Ribosomal RNA Gene.多重非结核分枝杆菌合并感染作为肺部非结核分枝杆菌病可能的加重因素:使用16S核糖体RNA基因的克隆文库分析
Chest. 2020 Dec;158(6):2304-2313. doi: 10.1016/j.chest.2020.06.027. Epub 2020 Jun 27.
9
The lung microbiota in nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病中的肺部微生物组。
PLoS One. 2023 May 26;18(5):e0285143. doi: 10.1371/journal.pone.0285143. eCollection 2023.
10
Gastroesophageal Reflux Disease Increases Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease.胃食管反流病增加非结核分枝杆菌性肺病易感性。
Chest. 2023 Feb;163(2):270-280. doi: 10.1016/j.chest.2022.08.2228. Epub 2022 Sep 7.

引用本文的文献

1
The gut-lung axis and microbiome dysbiosis in non-tuberculous mycobacterial infections: immune mechanisms, clinical implications, and therapeutic frontiers.非结核分枝杆菌感染中的肠-肺轴与微生物群失调:免疫机制、临床意义及治疗前沿
Gut Pathog. 2025 Jun 6;17(1):40. doi: 10.1186/s13099-025-00718-z.

本文引用的文献

1
Species to Ratio as a Potential Biomarker of Periodontitis Based on Salivary Microbiome Profiling.基于唾液微生物组分析的物种与比例作为牙周炎潜在生物标志物的研究
Ann Lab Med. 2024 Nov 1;44(6):600-603. doi: 10.3343/alm.2024.0043. Epub 2024 Apr 22.
2
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
3
Gastroesophageal Reflux Disease Increases Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease.
胃食管反流病增加非结核分枝杆菌性肺病易感性。
Chest. 2023 Feb;163(2):270-280. doi: 10.1016/j.chest.2022.08.2228. Epub 2022 Sep 7.
4
Gut Microbiome Profiles in Colonizations with the Enteric Protozoa in Korean Populations.韩国人群肠道原生动物定植中的肠道微生物群特征
Microorganisms. 2021 Dec 24;10(1):34. doi: 10.3390/microorganisms10010034.
5
Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients.肠道微生物组组成可以预测晚期肝细胞癌患者对nivolumab 的反应。
World J Gastroenterol. 2021 Nov 14;27(42):7340-7349. doi: 10.3748/wjg.v27.i42.7340.
6
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.系统生物学与囊性纤维化肺部微生物群-宿主相互作用中的胆汁酸信号传导
Antibiotics (Basel). 2021 Jun 24;10(7):766. doi: 10.3390/antibiotics10070766.
7
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南。
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
8
PICRUSt2 for prediction of metagenome functions.用于宏基因组功能预测的PICRUSt2
Nat Biotechnol. 2020 Jun;38(6):685-688. doi: 10.1038/s41587-020-0548-6.
9
Lung function and microbiota diversity in cystic fibrosis.囊性纤维化中的肺功能和微生物多样性。
Microbiome. 2020 Apr 2;8(1):45. doi: 10.1186/s40168-020-00810-3.
10
Rarefaction, Alpha Diversity, and Statistics.稀疏化、α多样性与统计学
Front Microbiol. 2019 Oct 23;10:2407. doi: 10.3389/fmicb.2019.02407. eCollection 2019.